InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Jordan Julie. Director active across 2 companies, notably Neurogene Inc.. Aggregated, 5 reports have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €16k. History available since 2 August 2023. The latest transaction was disclosed on 26 March 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Jordan Julie is a declarant with 5 filings in total. Among the 5 recent filings tracked, they cover the period from 2023-08-04 to 2026-03-30, with EUR 15679 in sales and EUR 0 in purchases. The companies mentioned are Neurogene Inc. and Homology Medicines, Inc., and the primary role is not provided.